Parties d'ouvrages collectifs (1)
  1. 1. Rodari, A., Poli, G., & Van Lint, C. (2022). Jurkat-Derived (J-Lat, J1.1, and Jurkat E4) and CEM-Derived T Cell Lines (8E5 and ACH-2) as Models of Reversible Proviral Latency. In Jurkat-Derived (J-Lat, J1.1, and Jurkat E4) and CEM-Derived T Cell Lines (8E5 and ACH-2) as Models of Reversible Proviral Latency, HIV Reservoirs (1 ed., pp. 3-15). Humana, New York, NY. doi:10.1007/978-1-0716-1871-4_1
    2.   Articles dans des revues avec comité de lecture (9)
  2. 1. Bellefroid, M., Rodari, A., Galais, M., Krijger, P., Tjalsma, S., Nestola, L., Plant, E., Vos, E., Cristinelli, S. S., Van Driessche, B., Vanhulle, C., Ait-Ammar, A., Burny, A., Ciuffi, A., De Laat, W., & Van Lint, C. (2022). Role of the cellular factor CTCF in the regulation of bovine leukemia virus latency and three-dimensional chromatin organization. Nucleic acids research, 50(6), 3190-3202. doi:10.1093/nar/gkac107
  3. 2. Rodari, A., Darcis, G., & Van Lint, C. (2021). The Current Status of Latency Reversing Agents for HIV-1 Remission. Annual review of virology, 8(1), 491-514. doi:10.1146/annurev-virology-091919-103029
  4. 3. Kula-Pacurar, A., Rodari, A., Darcis, G., & Van Lint, C. (2021). Shocking HIV-1 with immunomodulatory latency reversing agents. Seminars in immunology., 101478. doi:10.1016/j.smim.2021.101478
  5. 4. Kula-Pacurar, A., Rodari, A., Darcis, G., & Van Lint, C. (2021). Shocking HIV-1 with immunomodulatory latency reversing agents. Seminars in immunology, 51, 101478. doi:10.1016/j.smim.2021.101478
  6. 5. Ait-Ammar, A., Bellefroid, M., Daouad, F., Martinelli, V., Van Assche, J., Wallet, C., Rodari, A., De Rovere, M., Fahrenkrog, B., Schwartz, C., Van Lint, C., Gautier, V., & Rohr, O. (2021). Inhibition of HIV-1 gene transcription by KAP1 in myeloid lineage (C. Van Lint, V. Gautier and O. Rohr are co-last authors). Scientific reports, 11(1), 2692. doi:10.1038/s41598-021-82164-w
  7. 6. Dutilleul, A., Rodari, A., & Van Lint, C. (2020). Depicting HIV-1 Transcriptional Mechanisms: A Summary of What We Know. Viruses, 12(12). doi:10.3390/v12121385
  8. 7. Fauquenoy, S., Robette, G., Kula, A., Vanhulle, C., Bouchat, S., Delacourt, N., Rodari, A., Marban, C., Schwartz, C., Burny, A., Rohr, O., Van Driessche, B., & Van Lint, C. (2017). Repression of Human T-lymphotropic virus type 1 Long Terminal Repeat sense transcription by Sp1 recruitment to novel Sp1 binding sites. Scientific reports, 7, 43221. doi:10.1038/srep43221
  9. 8. Van Driessche, B., Rodari, A., Delacourt, N., Fauquenoy, S., Vanhulle, C., Burny, A., Rohr, O., & Van Lint, C. (2016). Characterization of new RNA polymerase III and RNA polymerase II transcriptional promoters in the Bovine Leukemia Virus genome. Scientific report, 6, 31125. doi:10.1038/srep31125
  10. 9. Thelie, A., Desiderio, S., Hanotel, J., Quigley, I., Van Driessche, B., Rodari, A., Borromeo, M., Kricha, S., Lahaye, F., Croce, J., Cerda-Moya, G., Ordono-Fernandez, J., Bolle, B., Lewis, K., Sander, M., Pierani, A., Schubert, M., Johnson, J., Kintner, C., Pieler, T., Van Lint, C., Henningfeld, K. A., Bellefroid, E., & Van Campenhout, C. (2015). Prdm12 specifies V1 interneurons through cross-repressive interactions with Dbx1 and Nkx6 genes in Xenopus. Development, 142(19), 3416-3428. doi:10.1242/dev.121871
    11.   Communications publiées lors de congrès ou colloques nationaux et internationaux (2)
  11. 1. Rodari, A., Van Driessche, B., Galais, M., Delacourt, N., Fauquenoy, S., Vanhulle, C., Kula, A., Burny, A., Rohr, O., & Van Lint, C. (2016). Characterization of new RNA polymerase III and RNA polymerase II transcriptional promoters in the Bovine Leukemia Virus genome. Frontiers of Retrovirology Conference 2016: Complex retroviruses, retroelements and their hosts Frontiers of Retrovirology(12-14 Septembre 2016: Erlangen)
  12. 2. Rodari, A., Van Driessche, B., Delacourt, N., Vanhulle, C., Burny, A., Van Den Broeke, A., Rohr, O., & Van Lint, C. (2015). In vivo characterisation of the BLV miRNA cluster. Abstract of the 17th International Conference on Human Retrovirology : HTLV & related Viruses
    13. << Précédent 1 2 3 4 Suivant >>